Cargando…
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery
The past decade has witnessed a paradigm shift in preclinical drug discovery with structure-based drug design (SBDD) making a comeback while high-throughput screening (HTS) methods have continued to generate disappointing results. There is a deficit of information between identified hits and the man...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Research Network of Computational and Structural Biotechnology (RNCSB) Organization
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962124/ https://www.ncbi.nlm.nih.gov/pubmed/24688704 http://dx.doi.org/10.5936/csbj.201302011 |